SCHEMBL24046990

SCHEMBL24046990

O=c1cc(-c2ccc(O)cn2)oc2c(Br)cc(Br)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 7/20 0.50
▸ CSNK2B P67870 7/20 0.50
▸ CSNK2A1 P68400 7/20 0.50
▸ CYP1A1 P04798 6/20 0.48
▸ CYP1B1 Q16678 6/20 0.48
▸ CYP1A2 P05177 4/20 0.48
▸ CYSLTR1 Q9Y271 3/20 0.45
▸ CYSLTR2 Q9NS75 1/20 0.45
▸ NQO1 P15559 1/20 0.40
▸ CSNK2A3 Q8NEV1 1/20 0.37
▸ TERT O14746 1/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046883 0.80 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046928 0.80 CSNK2A2 (0.65) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046880 0.79 CSNK2A2 (0.55) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046876 0.78 CSNK2A2 (0.54) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046882 0.78 CSNK2A2 (0.54) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046891 0.77 CSNK2A2 (0.65) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046874 0.77 CSNK2A2 (0.46) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL311288 0.76 LOXL2 (0.47) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046858 0.75 CSNK2A2 (0.57) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1
SCHEMBL24046873 0.75 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback